Zydus Lifesciences vs IOL Chemicals and Pharmaceuticals vs Indoco Remedies: Which Stock Should You Track

Zydus Lifesciences vs IOL Chemicals and Pharmaceuticals vs Indoco Remedies starts with the core numbers most investors compare within the Pharma Formulations (Fifth Fresh Set) segment: market capitalisation, valuation multiples, profitability and dividend yield. Figures below are sourced as of September 2026 and will shift with daily price moves.

All three names sit in the Pharma Formulations (Fifth Fresh Set) bucket, which makes them a natural set to place side by side rather than a random trio of unrelated businesses.

Click Here – Get Free Investment Predictions

Zydus Lifesciences, IOL Chemicals and Pharmaceuticals and Indoco Remedies: Company Overview

Zydus Lifesciences is a listed Indian company in the Pharma Formulations (Fifth Fresh Set) space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.

IOL Chemicals and Pharmaceuticals is a listed Indian company in the Pharma Formulations (Fifth Fresh Set) space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.

Indoco Remedies is a listed Indian company in the Pharma Formulations (Fifth Fresh Set) space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.

Zydus Lifesciences vs IOL Chemicals and Pharmaceuticals vs Indoco Remedies: Valuation and Profitability Snapshot

Metric	Zydus Lifesciences	IOL Chemicals and Pharmaceuticals	Indoco Remedies
Market Cap (approx.)	Rs 1,17,705 crore	Rs 5,982 crore	Rs 2,312 crore
PE Ratio (TTM)	25.63	35.57	NA
PB Ratio	4.34	3.33	2.46
Return on Equity (ROE)	18.59%	7.65%	-10.13%
EPS (TTM, Rs)	46.04	5.73	0.34
Dividend Yield	0.09%	0.49%	0.08%
Debt to Equity	0.46	0.08	1.16
Book Value per Share (Rs)	271.78	61.27	101.76

Check the Univest Screener for Live Data

On valuation, Zydus Lifesciences trades at a PE of 25.63 and a PB of 4.34, IOL Chemicals and Pharmaceuticals at a PE of 35.57 and a PB of 3.33, while Indoco Remedies trades at a PE of NA and a PB of 2.46. On return on equity, the three post 18.59%, 7.65% and -10.13% respectively, and on dividend yield they stand at 0.09%, 0.49% and 0.08%.

Zydus Lifesciences vs IOL Chemicals and Pharmaceuticals vs Indoco Remedies: Latest Quarterly Results

Company	Latest Quarter Revenue	Latest Quarter Net Profit	YoY Change (Revenue)	QoQ Change (Revenue)
Zydus Lifesciences	Rs 8,123.10 crore	Rs 952.40 crore	+20.7%	+5.2%
IOL Chemicals and Pharmaceuticals	Rs 764.44 crore	Rs 64.40 crore	+36.7%	+23.0%
Indoco Remedies	Rs 469.68 crore	Rs 65.44 crore	+6.4%	-1.2%

Quarterly figures above are the most recent reported quarter for each company (Q1 FY28, quarter ended June 2026), compared with the year-ago and preceding quarter.

Download the Univest iOS App or Univest Android App to track Zydus Lifesciences, IOL Chemicals and Pharmaceuticals and Indoco Remedies live prices.

What Should Investors Look at Beyond These Numbers?

Beyond the metrics above, investors comparing these three pharma formulations (fifth fresh set) names should track quarter-on-quarter revenue and margin trends, management commentary on demand and cost drivers, and any sector-specific regulatory developments, since a single-quarter snapshot can shift quickly.

Conclusion

Zydus Lifesciences vs IOL Chemicals and Pharmaceuticals vs Indoco Remedies highlights how differently three companies in the same pharma formulations (fifth fresh set) segment can score across valuation, profitability and dividend metrics, even when operating in a similar space. This comparison does not declare a winner; investors should weigh these figures against their own research and risk appetite. Please read the disclaimer below before making any investment decision.

FAQs on Zydus Lifesciences vs IOL Chemicals and Pharmaceuticals vs Indoco Remedies

What is the market cap difference between Zydus Lifesciences, IOL Chemicals and Pharmaceuticals and Indoco Remedies?

Ans. As of September 2026, Zydus Lifesciences has a market cap of approximately Rs 1,17,705 crore, IOL Chemicals and Pharmaceuticals is at approximately Rs 5,982 crore, and Indoco Remedies is at approximately Rs 2,312 crore.

Which of the three has the highest PE ratio?

Ans. Among Zydus Lifesciences, IOL Chemicals and Pharmaceuticals and Indoco Remedies, the PE ratios stand at 25.63, 35.57 and NA respectively as of September 2026.

Which of the three has the highest ROE?

Ans. Zydus Lifesciences, IOL Chemicals and Pharmaceuticals and Indoco Remedies post ROE of 18.59%, 7.65% and -10.13% respectively as of September 2026.

Which of these three stocks pays the highest dividend yield?

Ans. Zydus Lifesciences, IOL Chemicals and Pharmaceuticals and Indoco Remedies carry dividend yields of 0.09%, 0.49% and 0.08% respectively.

What is the debt to equity ratio for Zydus Lifesciences, IOL Chemicals and Pharmaceuticals and Indoco Remedies?

Ans. Zydus Lifesciences carries a debt to equity of 0.46, IOL Chemicals and Pharmaceuticals of 0.08, and Indoco Remedies of 1.16.

Which of the three trades at the highest price to book value?

Ans. Zydus Lifesciences, IOL Chemicals and Pharmaceuticals and Indoco Remedies trade at price to book ratios of 4.34, 3.33 and 2.46 respectively.

Is one of Zydus Lifesciences, IOL Chemicals and Pharmaceuticals or Indoco Remedies better than the others?

Ans. This comparison does not declare one stock better than another; each company scores differently across valuation, profitability and dividend metrics, and the right fit depends on an individual investor's own criteria and research.